[D-Ala2, D-Leu5] Enkephalin Attenuates Hepatic Ischemia–Reperfusion Injury in Cirrhotic Rats

[D-Ala2, D-Leu5] Enkephalin Attenuates Hepatic Ischemia–Reperfusion Injury in Cirrhotic Rats

Background and AimsHepatic ischemia–reperfusion injury (IRI) is a common phenomenon that occurs after liver transplantation and liver tumor surgery. It can cause liver dysfunction and recovery failure after liver surgery, even leading to acute liver failure. Our aim is to investigate the protective...

Full description

Bibliographic Details
Main Authors:	Jueying Liu, Yuan Wang, Qianling Pan, Xueqing Chen, Yifeng Qu, Hao Zhu, Li Zheng, Yinghui Fan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-05-01
Series:	Frontiers in Surgery
Subjects:	hepatic ischemia–reperfusion injury delta opioid receptor phosphatidylinositol-3-kinase (PI3K)/Akt pathway cirrhotic livers rats DADLE
Online Access:	https://www.frontiersin.org/articles/10.3389/fsurg.2022.839296/full

Similar Items

[D-Ala2, D-Leu5]-enkephalin (DADLE) provides protection against myocardial ischemia reperfusion injury by inhibiting Wnt/β-Catenin pathway
by: Linwen Liu, et al.
Published: (2024-02-01)

Delta opioid peptide [d-Ala2, d-Leu5] enkephalin confers neuroprotection by activating delta opioid receptor-AMPK-autophagy axis against global ischemia
by: Zelin Lai, et al.
Published: (2020-06-01)

Repeated Glucose Deprivation/Reperfusion Induced PC-12 Cell Death through the Involvement of FOXO Transcription Factor
by: Na Han, et al.
Published: (2016-09-01)

In silico analysis excavates potential biomarkers by constructing miRNA-mRNA networks between non-cirrhotic HCC and cirrhotic HCC
by: Bisha Ding, et al.
Published: (2019-07-01)

Comprehensive RNAseq analysis reveals PIK3CD promotes glioblastoma tumorigenesis by mediating PI3K-Akt signaling pathway
by: Zulfikar Azam, et al.
Published: (2020-01-01)

QT Interval Prolongation in Cirrhotic Cardiomyopathy
by: Tadelle A
Published: (2022-07-01)

Cirrhotic cardiomyopathy and liver transplantation
by: Yu. O. Malinovskaya, et al.
Published: (2016-09-01)

Idiopathic non-cirrhotic portal hypertension and its causes
by: O.M. Vlasova
Published: (2018-02-01)

Prognostic value of S100A4 and Glypican-3 in hepatocellular carcinoma in cirrhotic HCV patients
by: Mahmoud El-Bendary, et al.
Published: (2023-08-01)

A Low Daily Intake of Simple Sugars in the Diet Is Associated with Improved Liver Function in Cirrhotic Liver Transplant Candidates
by: Simona Parisse, et al.
Published: (2023-03-01)

The effects of d-ala2, d-leu5-enkephalin (dadle)"s continuous perfusion on erythrogram and biochemical profile in rats
by: AKYAZI I, et al.
Published: (2013-07-01)

Effect of Novel AKT Inhibitor Vevorisertib as Single Agent and in Combination with Sorafenib on Hepatocellular Carcinoma in a Cirrhotic Rat Model
by: Keerthi Kurma, et al.
Published: (2022-12-01)

Downregulation of hsa_circRNA_0001400 Helps to Promote Cell Apoptosis Through Disruption of the circRNA_0001400–miR-326 Sponge in Cervical Cancer Cells
by: Yantao Cai, et al.
Published: (2021-12-01)

Enhanced AKT phosphorylation of circulating B cells in patients with activated PI3Kδ syndrome
by: Osamu Ohara, et al.
Published: (2018-04-01)

Non-cirrhotic portal fibrosis
by: Venkatesan Mukta, et al.
Published: (2014-01-01)

Quercetin-3-O-β-D-glucuronide inhibits mitochondria pathway-mediated platelet apoptosis via the phosphatidylinositol-3-kinase/AKT pathway in immunological bone marrow failure
by: Le-Min Xia, et al.
Published: (2022-01-01)

Quercetin postconditioning attenuates myocardial ischemia/reperfusion injury in rats through the PI3K/Akt pathway
by: Y. Wang, et al.
Published: (2013-09-01)

Early Administration of Tolvaptan Can Improve Survival in Patients with Cirrhotic Ascites
by: Atsushi Hosui, et al.
Published: (2021-01-01)

IL-6 significantly correlates with p-STAT3 expression and presents high variceal bleeding with mortality in cirrhotic patients: A cross-sectional study
by: Jung-Ta Kao, et al.
Published: (2017-06-01)

Role of Galectin in Cardiovascular Conditions including Cirrhotic Cardiomyopathy
by: Hongqun Liu, et al.
Published: (2023-07-01)

Do you have to evaluate the heart of the cirrhotic patients?
by: Mohammed Hussien Ahmed, et al.
Published: (2023-05-01)

Neuroprotective and neuroregenerative potential of pharmacologically-induced hypothermia with D-alanine D-leucine enkephalin in brain injury
by: M Grant Liska, et al.
Published: (2018-01-01)

Herpesviruses in the Activated Phosphatidylinositol-3-Kinase-δ Syndrome
by: Jeffrey I. Cohen
Published: (2018-02-01)

Double-dose hepatitis B vaccination in cirrhotic patients on a liver transplant waiting list
by: Patricia R. Bonazzi, et al.

Neuroprotective effects of metformin on cerebral ischemia‐reperfusion injury by regulating PI3K/Akt pathway
by: Cailian Ruan, et al.
Published: (2021-10-01)

Urea Transporter Inhibitor 25a Reduces Ascites in Cirrhotic Rats
by: Yi Ying, et al.
Published: (2023-02-01)

Human hepatic met-enkephalin and delta opioid receptor-1 immunoreactivities in viral and autoimmune hepatitis
by: Vijaya D. Boyella, et al.
Published: (2008-07-01)

Approaches for Selective Vaccinations in Cirrhotic Patients
by: Giovanni Casella, et al.
Published: (2023-02-01)

Cirrhotic cardiomyopathy: the liver affects the heart
by: M.V.H. Carvalho, et al.
Published: (2019-02-01)

Evaluation of Echocardiographic Findings in Cirrhotic Patients
by: M Seidian, et al.
Published: (2005-10-01)

Divergences in Macrophage Activation Markers Soluble CD163 and Mannose Receptor in Patients With Non-cirrhotic and Cirrhotic Portal Hypertension
by: Nikolaj Worm Ørntoft, et al.
Published: (2021-06-01)

Effectiveness of intravenous infusion of N-acetylcysteine in cirrhotic patients undergoing major abdominal surgeries
by: Eman Sayed Ibrahim, et al.
Published: (2015-01-01)

Non-cirrhotic portal hypertension related to azathioprine therapy in a patient with Crohn’s disease
by: Jong Won Seo, et al.
Published: (2021-04-01)

Molecular Targeting of the Phosphoinositide-3-Protein Kinase (PI3K) Pathway across Various Cancers
by: Khine S. Shan, et al.
Published: (2024-02-01)

Zebrafish <i>pten</i> Genes Play Relevant but Distinct Roles in Antiviral Immunity
by: Patricia Pereiro, et al.
Published: (2020-04-01)

Pharmacological inhibition of Akt and downstream pathways modulates the expression of COX-2 and mPGES-1 in activated microglia
by: de Oliveira Antonio CP, et al.
Published: (2012-01-01)

Effects of Fibrinogen Levels and Platelet Counts on Viscoelastic Testing in Cirrhotic Patients
by: Tomescu Dana, et al.
Published: (2018-07-01)

Radiofrequency ablation of surface v/s intraparenchymal hepatocellular carcinoma in cirrhotic patients
by: Yashwant Patidar, et al.
Published: (2017-10-01)

An 18-Year-Old Man with Idiopathic Non-cirrhotic Portal Hypertension
by: Irene Saveria, et al.
Published: (2019-08-01)

Tolvaptan therapy of Chinese cirrhotic patients with ascites after insufficient diuretic routine medication responses: a phase III clinical trial
by: Jieting Tang, et al.
Published: (2020-11-01)